View Author
scopus: 16029370400

Reytan, N.

( N. Reytan)


patient psoriasis treatment therapy study evidence ciclosporin dermatol guideline effect table methotrexate response disease infection grade dermatology combination infliximab plaque psoriasis psoriasis vulgaris european efficacy pasi 75 response efalizumab vulgari result author reaction adalimumab phototherapy etanercept level 12 weeks suppl liver jeadv group academy venereology compilation journal increase 5–70 venereology guidelines pregnancy improvement side effects trial plaque pasi /bsa arthritis venereology pathirana arthritis symptom interaction acitretin malignancy measure © 2009 contraindication retinoid serum quality safety assessment reduction erythema blood 5 mg /kg randomized alefacept exposure induction therapy pasi 75 hepatitis tuberculosis fumaric acid esters recommendation maintenance month




1 Most Recent Publications

European S3-guidelines on the systemic treatment of psoriasis vulgaris (Article)
Pathirana, D. Ormerod, A.D. Dubertret, L. Eberlein, B. Erdmann, R. Ferguson, J. Girolomoni, G. Gisondi, P. Giunta, A. Griffiths, C.E.M. Hönigsmann, H. Hussain, M. Saiag, P. Jobling, R. Karvonen, S.L. Kemeny, L. Kopp, I. Leonardi, C. MacCarone, M. Menter, A. Mrowietz, U. Naldi, L. Nijsten, T.E.C. Smith, C. Ortonne, J.P. Orzechowski, H.D. Rantanen, T. Reich, K. Reytan, N. Richards, H. Thio, H.B. Kerkhof, P.C.M. van de Rzany, B. Spuls, P.I. Nast, A. Barker, J. Bos, J.D. Burmester, G.R. Chimenti, S.
2009-10-01